PTCOG Head and Neck Subcommittee Consensus Guidelines on Particle Therapy for the Management of Head and Neck Tumors.

IF 2.1 Q3 ONCOLOGY

International Journal of Particle Therapy Pub Date : 2021-06-25 eCollection Date: 2021-01-01 DOI:10.14338/IJPT-20-00071.1

Alexander Lin, John H C Chang, Ryan S Grover, Frank J P Hoebers, Upendra Parvathaneni, Samir H Patel, Juliette Thariat, David J Thomson, Johannes A Langendijk, Steven J Frank

{"title":"PTCOG Head and Neck Subcommittee Consensus Guidelines on Particle Therapy for the Management of Head and Neck Tumors.","authors":"Alexander Lin, John H C Chang, Ryan S Grover, Frank J P Hoebers, Upendra Parvathaneni, Samir H Patel, Juliette Thariat, David J Thomson, Johannes A Langendijk, Steven J Frank","doi":"10.14338/IJPT-20-00071.1","DOIUrl":null,"url":null,"abstract":"Purpose: Radiation therapy is a standard modality in the treatment for cancers of the head and neck, but is associated with significant short- and long-term side effects. Proton therapy, with its unique physical characteristics, can deliver less dose to normal tissues, resulting in fewer side effects. Proton therapy is currently being used for the treatment of head and neck cancer, with increasing clinical evidence supporting its use. However, barriers to wider adoption include access, cost, and the need for higher-level evidence.Methods: The clinical evidence for the use of proton therapy in the treatment of head and neck cancer are reviewed here, including indications, advantages, and challenges.Results: The Particle Therapy Cooperative Group Head and Neck Subcommittee task group provides consensus guidelines for the use of proton therapy for head and neck cancer.Conclusion: This report can be used as a guide for clinical use, to understand clinical trials, and to inform future research efforts.","PeriodicalId":36923,"journal":{"name":"International Journal of Particle Therapy","volume":" ","pages":"84-94"},"PeriodicalIF":2.1000,"publicationDate":"2021-06-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8270078/pdf/","citationCount":"2","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"International Journal of Particle Therapy","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.14338/IJPT-20-00071.1","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2021/1/1 0:00:00","PubModel":"eCollection","JCR":"Q3","JCRName":"ONCOLOGY","Score":null,"Total":0}

引用次数: 2

Abstract

Purpose: Radiation therapy is a standard modality in the treatment for cancers of the head and neck, but is associated with significant short- and long-term side effects. Proton therapy, with its unique physical characteristics, can deliver less dose to normal tissues, resulting in fewer side effects. Proton therapy is currently being used for the treatment of head and neck cancer, with increasing clinical evidence supporting its use. However, barriers to wider adoption include access, cost, and the need for higher-level evidence.

Methods: The clinical evidence for the use of proton therapy in the treatment of head and neck cancer are reviewed here, including indications, advantages, and challenges.

Results: The Particle Therapy Cooperative Group Head and Neck Subcommittee task group provides consensus guidelines for the use of proton therapy for head and neck cancer.

Conclusion: This report can be used as a guide for clinical use, to understand clinical trials, and to inform future research efforts.

查看原文本刊更多论文

PTCOG头颈部小组委员会头颈部肿瘤颗粒治疗的共识指南。

目的:放射治疗是头颈部癌症治疗的标准方式，但与显著的短期和长期副作用相关。质子治疗以其独特的物理特性，对正常组织的剂量更小，副作用更小。质子治疗目前正被用于头颈癌的治疗，越来越多的临床证据支持其使用。然而，更广泛采用的障碍包括获取、成本和需要更高层次的证据。方法:回顾质子治疗头颈癌的临床证据，包括适应症、优势和挑战。结果:粒子治疗合作小组头颈小组委员会任务小组为头颈癌质子治疗的使用提供了共识指南。结论:本报告可作为临床使用的指导，了解临床试验，并为今后的研究工作提供信息。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊